Christian Ehmann
Stock Analyst at Berenberg Bank
(0.49)
# 4,289
Out of 4,659 analysts
189
Total ratings
41.9%
Success rate
-3.6%
Average return
Main Sectors:
Stocks Rated by Christian Ehmann
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIT: 1SXP SCHOTT Pharma AG & Co. KGaA | Maintained: Buy | €24.00 → €27.00 | €22.00 | +22.73% | 8 | Aug 14, 2026 | |
| ETR: EVT Evotec SE | Downgraded: Hold | €9.70 → €3.60 | €3.32 | +8.43% | 39 | Jul 16, 2026 | |
| SWX: KURN Kuros Biosciences AG | Initiated Coverage: Buy | CHF 32.00 | CHF 21.76 | +47.06% | 1 | Jul 7, 2026 | |
| ETR: GXI Gerresheimer AG | Maintained: Hold | €20.00 → €24.00 | €27.98 | -14.22% | 14 | Jul 3, 2026 | |
| ETR: DMP Dermapharm Holding SE | Maintained: Hold | €41.00 | €40.05 | +2.37% | 4 | Aug 26, 2025 | |
| ETR: FYB Formycon AG | Maintained: Buy | €40.00 | €18.40 | n/a | 14 | Aug 13, 2025 | |
| ETR: DRW3 Drägerwerk AG & Co. KGaA | Maintained: Buy | €85.00 | €110.20 | n/a | 21 | Jul 14, 2025 | |
| ETR: FRE Fresenius SE & Co. KGaA | Maintained: Buy | €47.00 | €46.73 | n/a | 23 | May 7, 2025 | |
| ETR: M12 M1 Kliniken AG | Maintained: Buy | €26.00 → €28.00 | €18.54 | n/a | 15 | May 6, 2025 | |
| ETR: FME Fresenius Medical Care AG | Maintained: Hold | €43.00 | €40.72 | n/a | 20 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €12.80 → €5.90 | €2.87 | n/a | 3 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €5.60 | €2.85 | n/a | 1 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €16.50 → €17.90 | €0.91 | n/a | 11 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €30.00 → €33.00 | €12.90 | n/a | 10 | Nov 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €41.00 → €56.00 | €1.11 | n/a | 2 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €4.20 → €3.50 | €0.02 | n/a | 3 | May 5, 2022 |
SCHOTT Pharma AG & Co. KGaA
Aug 14, 2026
Maintained: Buy
Price Target: €24.00 → €27.00
Current: €22.00
Upside: +22.73%
Evotec SE
Jul 16, 2026
Downgraded: Hold
Price Target: €9.70 → €3.60
Current: €3.32
Upside: +8.43%
Kuros Biosciences AG
Jul 7, 2026
Initiated Coverage: Buy
Price Target: CHF 32.00
Current: CHF 21.76
Upside: +47.06%
Gerresheimer AG
Jul 3, 2026
Maintained: Hold
Price Target: €20.00 → €24.00
Current: €27.98
Upside: -14.22%
Dermapharm Holding SE
Aug 26, 2025
Maintained: Hold
Price Target: €41.00
Current: €40.05
Upside: +2.37%
Formycon AG
Aug 13, 2025
Maintained: Buy
Price Target: €40.00
Current: €18.40
Upside: n/a
Drägerwerk AG & Co. KGaA
Jul 14, 2025
Maintained: Buy
Price Target: €85.00
Current: €110.20
Upside: n/a
Fresenius SE & Co. KGaA
May 7, 2025
Maintained: Buy
Price Target: €47.00
Current: €46.73
Upside: n/a
M1 Kliniken AG
May 6, 2025
Maintained: Buy
Price Target: €26.00 → €28.00
Current: €18.54
Upside: n/a
Fresenius Medical Care AG
Feb 25, 2025
Maintained: Hold
Price Target: €43.00
Current: €40.72
Upside: n/a
Nov 11, 2024
Maintained: Buy
Price Target: €12.80 → €5.90
Current: €2.87
Upside: n/a
Feb 7, 2024
Maintained: Hold
Price Target: €5.60
Current: €2.85
Upside: n/a
Dec 14, 2023
Maintained: Buy
Price Target: €16.50 → €17.90
Current: €0.91
Upside: n/a
Nov 21, 2023
Maintained: Buy
Price Target: €30.00 → €33.00
Current: €12.90
Upside: n/a
May 30, 2023
Maintained: Buy
Price Target: €41.00 → €56.00
Current: €1.11
Upside: n/a
May 5, 2022
Maintained: Buy
Price Target: €4.20 → €3.50
Current: €0.02
Upside: n/a